A long-acting LEAP2 analog reduces hepatic steatosis and inflammation and causes marked weight loss in mice.
Shankar K, Metzger NP, Lawrence C, Gupta D, Osborne-Lawrence S, Varshney S, Singh O, Richard CP, Zaykov AN, Rolfts R, DuBois BN, Perez-Tilve D, Mani BK, Hammer STG, Zigman JM.
Shankar K, et al. Among authors: richard cp.
Mol Metab. 2024 Jun;84:101950. doi: 10.1016/j.molmet.2024.101950. Epub 2024 Apr 30.
Mol Metab. 2024.
PMID: 38697291
Free PMC article.